Skip to main content
Clinical Trials/IRCT20201218049749N1
IRCT20201218049749N1
Completed
Phase 3

A comparison of vaginal misoprostol and vaginal evening primrose oil in first trimester termination

Kashan University of Medical Sciences0 sites72 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Spontaneous abortion.
Sponsor
Kashan University of Medical Sciences
Enrollment
72
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Pregnant women go to Beheshti Hospital for up to 14 weeks to terminate their pregnancy

Exclusion Criteria

  • Uncontrolled seizures
  • Uncontrolled blood pressure
  • Chronic lung disease
  • Mitral valve stenosis
  • History of known allergy to prostaglandin E1
  • Inflammatory bowel disease
  • Sensitivity to evening primrose
  • Coagulation disease
  • Schizophrenia and phenothiazine use
  • Cone biopsy of the cervix

Outcomes

Primary Outcomes

Not specified

Similar Trials